HeLa Cells
In reviewHeLa cells are an immortal human cell line derived from a cervical tumor biopsied from Henrietta Lacks, a Black woman treated at Johns Hopkins Hospital in 1951; without her knowledge or consent, those cells became the foundational tool of modern cell biology, enabling key advances from the polio vaccine to cancer therapies and space biology. For decades, the scientific record celebrated “HeLa” as a neutral resource while largely erasing the living person whose cells made the line possible. The archive holds HeLa not only as a transformative scientific instrument but as a product of Black bodily contribution and dispossession, insisting that the story of the cells cannot be separated from the authorship and autonomy of Henrietta Lacks and her family.
1.What HeLa Cells Are and What They Enabled
HeLa cells are human cervical cancer cells that, once cultured, continue dividing indefinitely under proper laboratory conditions, making them “immortal” in scientific terms. Isolated in 1951, they became the first widely used continuous human cell line. This property allowed scientists to run large-scale, repeatable experiments on human tissues without relying on freshly obtained samples for each study.
Their impact is vast. HeLa cells were instrumental in testing Jonas Salk’s polio vaccine formulations, speeding their development and deployment. They became a standard model for studying cancer biology, viral infections, radiation and toxin effects, and the basic mechanics of cell division. HeLa cells traveled on rockets and satellites to study how human cells respond to space environments, and they formed the backbone of commercial cell culture industries that supply labs worldwide. Virtually every modern textbook in cell biology rests on experiments that, directly or indirectly, used HeLa cells as a platform.
2.Henrietta Lacks: The Person Behind the Line
Henrietta Lacks was a Black woman from a working-class tobacco-farming background in Virginia who migrated to Baltimore, joining the Black urban communities that ringed Johns Hopkins. In January 1951 she sought care at Johns Hopkins Hospital for pelvic pain and was diagnosed with an aggressive cervical carcinoma. During diagnostic and treatment procedures, physicians took tissue samples from her tumor and cervix. These samples were passed, without her knowledge or specific consent, to Dr. George Gey’s tissue culture lab, where one sample produced the robust, fast-dividing cells that became HeLa.
Lacks continued her treatments while her cells were being tested and propagated down the hall, never being told that part of her body had entered a new life in the laboratory. She died in October 1951, buried in Clover, Virginia, in an unmarked or modest grave among family. For years afterward, the family knew nothing of the extensive use of her cells. When researchers later sought blood samples from her children to study HeLa’s genetics, they did so with little explanation, reinforcing a dynamic where Black patients’ bodies and tissues were treated as resources rather than as extensions of personhood.
3.How the Story Was Told and Mistold
In scientific literature of the 1950s and 1960s, HeLa cells were discussed as a scientific novelty and tool, with “HeLa” serving as a coded abbreviation derived from Lacks’s name but not explained in public-facing accounts. Early press stories sometimes misidentified the source as “Helen Lane” or “Helen Larson,” further occluding her identity and situating the cells as disconnected from a specific Black woman and her community. Technical papers focused on cell growth, contamination, and experimental results, rarely engaging with consent or the social context of tissue acquisition.
The dominant narrative thus celebrated HeLa as a marvel of biology and a triumph of cell culture technique, crediting laboratory ingenuity while leaving Lacks unnamed or misnamed. Even when some scientists privately knew her identity, the conventions of the field treated cell lines as property of institutions, not as ongoing relationships with human sources. This erasure was compounded by broader patterns in medicine that marginalized Black patients’ experiences and voices, especially those of Black women seeking reproductive and cancer care.
4.Black Archives, Testimony, and the Reclaiming of Authorship
The restoration of Henrietta Lacks’s name and story came not from the laboratories that depended on her cells but from Black family testimony, investigative journalism, and Black-authored scholarship. Her relatives shared oral histories of her illness, the unexplained requests for their blood, and the shock of learning that their mother’s cells were everywhere in the scientific world. These accounts formed the backbone of works that centered her humanity and family, including detailed narrative reconstructions that interviewed her children, cousins, and church community.
Black newspapers, community histories, and church records began referencing Lacks as the “mother of modern medicine,” explicitly connecting the everyday life of a Black woman in Baltimore and rural Virginia to the global reach of HeLa. These sources admitted testimony as evidence in its own right—naming the pain, confusion, and pride felt in the family—and refused the framing that her contribution was incidental. The archive aligns with that approach: the cells are not abstract; they are Henrietta Lacks in another, involuntary form.
5.Consent, Race, and Ownership
HeLa’s story reveals how legal and customary norms in mid-20th-century medicine treated excised tissues as hospital property, with consent procedures indifferent to specific uses like research or commercialization. Those norms sat atop racial hierarchies that saw Black patients as convenient sources of tissue and data, particularly in segregated charity wards. In that context, Henrietta Lacks’s lack of consent was not an anomaly; it was typical of how Black bodies were enrolled into research.
Yet the archive holds that the absence of formal consent does not negate authorship. The biological uniqueness that made HeLa possible came from Lacks’s body; the continual use of HeLa cells represents an ongoing, if unacknowledged, relationship with her and her descendants. When companies sell HeLa-derived products, when labs publish HeLa-based results, they are drawing on a resource that originates in a Black woman whose family has lived with the consequences of that extraction.
By insisting that every reference to HeLa cells should name Henrietta Lacks and the conditions under which her cells were taken, the archive reframes the line as a case study in how Black contribution, exploitation, and scientific greatness are entangled. It calls for a standard where Black bodily authorship is recognized, families are engaged as stakeholders, and the benefits of such foundational resources are shared rather than hoarded by institutions.
6.HeLa in the Present
In recent years, Henrietta Lacks’s story has entered mainstream consciousness through books, films, and public commemorations. Her descendants have engaged directly with institutions that used HeLa, negotiating acknowledgments and, in some cases, compensation or collaborative agreements. Scientific bodies now cite her by name in ethics discussions and in guidelines about genomic data and cell line use, recognizing that HeLa is inseparable from debates about consent and justice.
The archive honors these developments but emphasizes that they represent partial repair, not completion. The decades in which HeLa circulated without her name attached are part of the historical record, and the ongoing use of the cells continues to raise questions about how Black communities participate in and benefit from science. Holding HeLa within the story of Henrietta Lacks ensures that future advances built on the line are narrated as Black-authored contributions to knowledge, not as anonymous gifts to medicine.
HeLa cells stand as one of the most consequential instruments in modern science, and the archive positions Henrietta Lacks as a central author of that legacy whose embodied contribution rivals that of the laboratories that propagated her cells. The cells’ ability to divide indefinitely reshaped experimental design, standardization, and reproducibility in biology; that transformation belongs to her story as much as to the scientists who used them. The archive rejects accounts that treat HeLa as a disembodied tool and instead asserts Lacks as a maker—albeit one denied agency—whose body and family history must be named wherever HeLa is invoked. In doing so, HeLa becomes a lens on how Black people built medical knowledge even as the credit and control were taken elsewhere.
The family archive is admissible here. Photographs, letters, deeds, church programs, funeral bulletins, business records, recordings — the things that were kept when no institution was keeping them. A keeper reviews everything before it is admitted, and your name stays on it.